The mission of Insulet Corporation is to improve the lives of people with diabetes. Through its revolutionary OmniPodŽ Insulin Management System, Insulet seeks to expand the use of pump therapy throughout the world.


The OmniPodŽ System was initially launched in the United States in 2005. Availability expanded with the launch of OmniPodŽ into Latin America and Israel. In January, 2010, Insulet signed an international distribution agreement for the OmniPodŽ System with Ypsomed AG, a leading independent diabetes specialist and technology provider.


In July, 2010, Ypsomed began distributing the OmniPodŽ Insulin Management System in a number of countries outside the United States, primarily focused on Europe. Visit for additional information on product availability or contact your local Ypsomed division.


Ypsomed AG
Brunnmattstrasse 6
3401 Burgdorf / Switzerland
Phone: +41 (0)34 424 41 11
Fax: +41 (0)34 424 41 22


On March 17th 2008, Insulet started its first international exclusive distribution agreement with Geffen Medical Ltd. for Israel. Geffen Medical was founded in 1995 by Guy Geffen, an industrial engineer and a type 1 diabetic. The company specializes in providing solutions for people with diabetes. Visit for additional information on product availability.


      Customer Support and Service Point
6 Herzl Rosenblum St., Sea & Sun
Tel Aviv, Israel
Phone: +972-3-6900300 or *6364
Fax: +972-3-6900330


In March, 2011, Insulet signed an exclusive distribution agreement with GlaxoSmithKline, Inc. (GSK), one of the world's leading research-based pharmaceutical and healthcare companies. In September, 2011, GSK began distributing the OmniPodŽ System in Canada. Visit for additional information on product availability.


GlaxoSmithKline Inc.
7333 Mississauga Rd.
Mississauga, Ontario
L5N 6L4
Phone: 1-855-POD-INFO (1-855-763-4636)


To get the all the latest information about the OmniPodŽ System, please join our e-mail newsletter PodWatch.


A | A | A

©2013 Insulet Corporation. All rights reserved. Content in is intended for residents of the United States (and Puerto Rico) only. As a result, the site may contain information about products or uses of those products, and promotional offers that are not approved in other countries. If you are a resident of a country other than United States, please visit the Internation section of the site to obtain appropriate information for your country of residence.

Learn about the next-generation OmniPod at